TY - JOUR
T1 - Lithium ions have a potent and selective inhibitory effect on cyclic GMP formation stimulated by neurotensin, angiotensin II and bradykinin
AU - Kanba, Shigenobu
AU - Pfenning, Michael
AU - Kanba, Kiyoko S.
AU - Richelson, Elliott
N1 - Funding Information:
This work was supported by the Mayo Foundation and USPHS Grant MH27692 from N.I.M.H.
PY - 1986/7/15
Y1 - 1986/7/15
N2 - The effect of lithium ion (Li+) on receptor-mediated synthesis of cyclic GMP, a putative second messenger, was examined using intact murine neuroblastoma cells (clone N1E-115). Lithium chloride potently inhibited cyclic GMP formation stimulated by the neuropeptides, neurotensin, angiotensin II and bradykinin in an identical concentration-dependent (IC50s of around 12 mM), saturable and reversible manner. In the presence of veratridine, an alkaloid which by stimulating sodium channels can increase Li+ entry into the cells, Li+ inhibited neurotensin-stimulated cyclic GMP formation more potently (IC50 = 7 mM). No effect of Li+ was observed on phosphodiesterase (EC 3.1.4.17) activity. These results suggest that Li+ may interfere with the function of these receptors through its inhibitory effect at a common site in the pathway of receptor-mediated cyclic GMP formation.
AB - The effect of lithium ion (Li+) on receptor-mediated synthesis of cyclic GMP, a putative second messenger, was examined using intact murine neuroblastoma cells (clone N1E-115). Lithium chloride potently inhibited cyclic GMP formation stimulated by the neuropeptides, neurotensin, angiotensin II and bradykinin in an identical concentration-dependent (IC50s of around 12 mM), saturable and reversible manner. In the presence of veratridine, an alkaloid which by stimulating sodium channels can increase Li+ entry into the cells, Li+ inhibited neurotensin-stimulated cyclic GMP formation more potently (IC50 = 7 mM). No effect of Li+ was observed on phosphodiesterase (EC 3.1.4.17) activity. These results suggest that Li+ may interfere with the function of these receptors through its inhibitory effect at a common site in the pathway of receptor-mediated cyclic GMP formation.
UR - http://www.scopus.com/inward/record.url?scp=0022447408&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022447408&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(86)90745-4
DO - 10.1016/0014-2999(86)90745-4
M3 - Article
C2 - 3019710
AN - SCOPUS:0022447408
SN - 0014-2999
VL - 126
SP - 111
EP - 116
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-2
ER -